Ibumax (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. By lowering prostaglandin levels, it reduces pain signaling, lowers fever, and diminishes inflammation at the site of injury or disease.

The appropriate dose of Ibumax is determined by the prescribing clinician based on the patient’s age, weight, medical condition, and response to therapy. Dosage recommendations follow local regulatory guidelines and should be confirmed with the treating healthcare provider.

Ibuprofen is generally avoided in the third trimester of pregnancy because of potential risks to the fetus. Use during the first two trimesters should only occur if clearly needed and prescribed by a qualified professional. Limited data are available for breastfeeding, so a healthcare provider should assess the risk‑benefit ratio before use.

To place an order, submit an enquiry on the Ibumax product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Ibumax (ibuprofen) shares the core NSAID properties of analgesia, antipyresis, and anti‑inflammation with agents such as naproxen or diclofenac. Compared with some longer‑acting NSAIDs, ibuprofen has a relatively short half‑life, which may allow more flexible dosing but may also require more frequent administration for sustained effect.

Ibumax should be stored at room temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiration date indicated on the label.

Ibumax is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with food or milk may reduce the likelihood of gastrointestinal discomfort. The exact administration instructions are provided by the prescribing clinician.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, acute kidney injury, and an increased risk of cardiovascular events like heart attack or stroke, especially with high‑dose or prolonged use. Patients should seek immediate medical attention if they notice signs of these conditions.

Ibumax should be avoided in individuals with a known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulceration or bleeding, patients in the third trimester of pregnancy, and persons with severe renal or hepatic impairment unless specifically directed by a physician.